Contemporary drug development--dilemmas

Area of Science:

• Pharmacology and Drug Development
• Health Economics
• Regulatory Science

Background:

• Medicinal agents have historically provided significant societal benefits.
• Future therapeutic innovations hold even greater potential value for public health.
• Current trends indicate a concerning decrease in commitment to fundamental drug research.

Purpose of the Study:

• To analyze the decline in industry investment in drug discovery.
• To identify the complex regulatory, economic, and psychological factors contributing to this decline.
• To propose and discuss potential corrective actions to stimulate drug innovation.

Main Methods:

• Review of industry trends in pharmaceutical research and development.
• Analysis of economic factors influencing drug innovation.
• Examination of regulatory and psychological impacts on drug discovery.
• Formulation of recommendations for policy and practice.

Main Results:

• Industry is allocating fewer resources to the discovery of new chemical entities.
• The business of discovering new drugs is becoming increasingly difficult and less economically attractive.
• A complex interplay of regulatory, economic, and psychological factors underlies the decline in drug innovation.

Conclusions:

• The reduction in basic drug research commitment poses a significant risk to future drug availability.
• Urgent attention to the identified factors is necessary to reverse the negative trend in drug innovation.
• Implementing proposed corrective actions could help restore and enhance the pipeline of new medicinal agents.